<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000723438">
  <TermName>tapentadol hydrochloride</TermName>
  <TermPronunciation>(tuh-PEN-tuh-dol HY-droh-KLOR-ide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat moderate to severe pain. It binds to opioid receptors and other molecules in the central nervous system. Tapentadol hydrochloride is a type of opioid and a type of analgesic agent. Also called Nucynta.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000734732" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tapentadol hydrochloride&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000734733" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de tapentadol&quot;" language="es" id="_4"/>
  <SpanishTermName>clorhidrato de tapentadol</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para tratar el dolor de moderado a grave. Se une a los receptores de opioides y otras moléculas del sistema nervioso central. El clorhidrato de tapentadol es un tipo de opioide y de analgésico. También se llama Nucynta.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2012-04-11</DateFirstPublished>
</GlossaryTerm>
